Skip to Main Content

Advertisement

Skip Nav Destination

Entry Threats and Pricing in the Generic Drug Industry

The Review of Economics and Statistics (2014) 96 (2): 214–228.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
  • Ivan Lugovoi
  • Dimitrios A. Andritsos
  • Claire Senot
Manufacturing & Service Operations Management (2022) 24 (3): 1760.
  • Cici McNamara
  • Natalia Serna
Health Economics (2022) 31 (11): 2311.
  • Bill Hu
  • Joon Ho Hwang
  • Christine Jiang
  • Jim Washam
  • Li Zeng
Finance Research Letters (2022) 46: 102357.
  • Germán Bet
International Journal of Industrial Organization (2021) 75: 102705.
  • RICHARD G. FRANK
  • THOMAS G. MCGUIRE
  • IAN NASON
The Milbank Quarterly (2021) 99 (3): 828.
  • Victoria Serra-Sastre
  • Simona Bianchi
  • Jorge Mestre-Ferrandiz
  • Phill O’Neill
The European Journal of Health Economics (2021) 22 (2): 229.
  • Daniel Hosken
  • David Schmidt
  • Matthew C. Weinberg
The Journal of Industrial Economics (2020) 68 (1): 1.
  • Kirk W. Kerr
  • Lukas J. Glos
Pharmaceutical Medicine (2020) 34 (1): 19.
  • J. M. Binner
  • F. Ciardiello
  • L. R. Fletcher
  • V. N. Kolokoltsov
International Game Theory Review (2019) 21 (02): 1940007.
  • Luke M. Olson
  • Brett W. Wendling
Review of Industrial Organization (2018) 53 (1): 139.
  • Cathy Ge Bao
  • Maggie Xiaoyang Chen
American Economic Journal: Applied Economics (2018) 10 (4): 120.
  • Shraddha Chakradhar
  • Roxanne Khamsi
Nature Medicine (2017) 23 (10): 1114.
  • Daniel S. Hosken
  • Luke M. Olson
  • Loren K. Smith
Economic Inquiry (2016) 54 (1): 342.
Close Modal

or Create an Account

Close Modal
Close Modal